Imaging Flow-Cytometer Based Detection of ALK and MDM2 Amplification in Neuroblastoma Cell Lines

被引：0
|
作者：
Wright, J. H. [1 ]
Humphreys, A. [2 ]
Gabriel, A. S. [1 ]
Bown, N. [2 ]
Chen, L. [1 ]
Jamieson, D. [1 ]
Tweddle, D. A. [1 ]
机构：
[1] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[2] Inst Genet Med, Northern Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-0494
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
    Wang, Hui Qin
    Halilovic, Ensar
    Li, Xiaoyan
    Liang, Jinsheng
    Cao, Yichen
    Rakiec, Daniel P.
    Ruddy, David A.
    Jeay, Sebastien
    Wuerthner, Jens U.
    Timple, Noelito
    Kasibhatla, Shailaja
    Li, Nanxin
    Williams, Juliet A.
    Sellers, William R.
    Huang, Alan
    Li, Fang
    [J]. ELIFE, 2017, 6
  • [2] ANALYSIS OF GLIOMA CELL-LINES FOR AMPLIFICATION AND OVEREXPRESSION OF MDM2
    HE, J
    REIFENBERGER, G
    LIU, L
    COLLINS, VP
    JAMES, CD
    [J]. GENES CHROMOSOMES & CANCER, 1994, 11 (02): : 91 - 96
  • [3] NON-SYNTENIC AMPLIFICATION OF MDM2 AND MYCN IN HUMAN NEUROBLASTOMA
    CORVI, R
    SAVELYEVA, L
    BREIT, S
    WENZEL, A
    HANDGRETINGER, R
    BARAK, J
    OREN, M
    AMLER, L
    SCHWAB, M
    [J]. ONCOGENE, 1995, 10 (06) : 1081 - 1086
  • [4] CYTOGENETIC EVOLUTION OF MYCN AND MDM2 AMPLIFICATION IN THE NEUROBLASTOMA LS TUMOR AND ITS CELL-LINE
    CORVI, R
    SAVELYEVA, L
    AMLER, L
    HANDGRETINGER, R
    SCHWAB, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) : 520 - 523
  • [5] Portable Imaging Flow-cytometer Using Deep Learning-based Holographic Image Reconstruction
    Gorocs, Zoltan
    Tamamitsu, Miu
    Bianco, Vittorio
    Wolf, Patrick
    Roy, Shounak
    Shindo, Koyoshi
    Yanny, Kyrollos
    Wu, Yichen
    Koydemir, Hatice Ceylan
    Rivenson, Yair
    Ozcan, Aydogan
    [J]. 2019 CONFERENCE ON LASERS AND ELECTRO-OPTICS (CLEO), 2019,
  • [6] p53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines
    Taylor, AC
    Shu, LL
    Danks, MK
    Poquette, CA
    Shetty, S
    Thayer, MJ
    Houghton, PJ
    Harris, LC
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (02): : 96 - 103
  • [7] Radiosensitization of solid tumor cell lines by an MDM2 inhibitor
    Cerna, David
    Li, Hongyun
    Flaherty, Siobhan
    Carter, Donna
    Coleman, C. Norman
    Yoo, Stephen
    [J]. CANCER RESEARCH, 2011, 71
  • [8] MDM2 amplification and immunohistochemical expression in sarcomatoid renal cell carcinoma
    Suster, David
    Ronen, Shira
    Peterson, Jess F.
    Mackinnon, Alexander C.
    Hes, Ondrej
    Suster, Saul
    Lin, Douglas I.
    [J]. HUMAN PATHOLOGY, 2019, 87 : 28 - 36
  • [9] MDM2 and MDMX status as a determinant of in vitro cellular sensitivity to MDM2 antagonists in human tumour cell lines
    Lu, X.
    Liu, J.
    Watson, A.
    Hardcastle, I. R.
    Griffin, R. J.
    Golding, B. T.
    Newell, D. R.
    Lunec, J.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 137 - 137
  • [10] Case presentation: sarcomatoid renal cell carcinoma with MDM2 amplification
    Cugura, T.
    Jeruc, J.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S367 - S367
12345